Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma
Part of paid clinical trials in Cleveland, Ohio.
- Sponsor
- National Cancer Institute (NCI)
- Study ID
- NCT00084617
- Phase
- PHASE2
- Status
- Completed
Conditions
- Adenocarcinoma of the Gastroesophageal Junction
- Diffuse Adenocarcinoma of the Stomach
- Intestinal Adenocarcinoma of the Stomach
- Mixed Adenocarcinoma of the Stomach
- Recurrent Gastric Cancer
- Stage IIIA Gastric Cancer
- Stage IIIB Gastric Cancer
- Stage IIIC Gastric Cancer
- Stage IV Gastric Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- oxaliplatin — DRUGGiven IV
- irinotecan hydrochloride — DRUGGiven IV
- capecitabine — DRUGGiven orally
Study Details
Drugs used in chemotherapy, such as oxaliplatin, irinotecan, and capecitabine, work in different ways to stop tumor cells from dividing so they stop growing or die. Giving more than one chemotherapy drug may kill more tumor cells. This phase II trial is studying how well giving oxaliplatin together with irinotecan and capecitabine works in treating patients with metastatic or inoperable locally advanced gastric cancer or gastroesophageal junction adenocarcinoma (cancer).
Key Dates
- Start date
- Mar 31, 2004
- Status verified
- Jul 2013
- Primary completion
- Oct 31, 2008
- Completion
- Dec 31, 2008
Study Design
- Enrollment
- 39 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Treatment (oxaliplatin, irinotecan, capecitabine)Patients receive oxaliplatin IV over 2 hours and irinotecan IV over 30 minutes on days 1, 8, 15, and 22 and oral capecitabine twice daily on days 1-5, 8-12, 15-19, and 22-26. Courses repeat every 42 days in the absence of disease progression or unacceptable toxicity.
Primary Outcome Measure
Response Rates (RR) in Metastatic Gastric/GE Junction Tumors [ Time Frame: at 12 weeks (after 2 cycles of treatment) ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Case Western Reserve University | Cleveland | Ohio | 44106 | - |
Find similar trials in Cleveland, OH
By research site
Related Studies
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruiting · University of California, San Francisco · San Francisco, California